Jubay, E. T. (2013). Institutionalization of a "Drug-Free Workplace" through implementation of the provisions of RA 9165 and the dangerous Drugs Board Regulation Number 2, Series of 2004 (Unpublished master's thesis). Public Management Development Program, Development Academy of the Philippines.

Public Management Development Program Middle Managers Class (MMC) Batch 2: Habi Thesis (MMC)--Development Academy of the Philippines.

"The Comprehensive Dangerous Drugs Act of 2002," or the Republic Act 9165, gave birth to and mandated the Philippine Drug Enforcement Agency (PDEA) to be the lead Agency in the implementation of the anti-drug law. One of PDEA's mission is to implement the regulations of the Dangerous Drugs Board (DDB) which is the policy-making body. A Board Regulation dictates the institutionalization of a "Drug-Free Workplace" policy in all government agencies. It is unfortunate that before the implementation of the ReP, there was no document that defined the PDEA as a "Drug-Free" workplace. It is ironic that the very agency mandated to take the lead in implementing the anti-drug law is not "certified" as being "drug-free" nearly a decade after the Regulation was issued. The objective of this Re-Entry Project is to institutionalize the policy of a "Drug-Free Workplace" in compliance with the DDB regulation and, more broadly, with the President's Social Contract on "Good Governance and Rule of Law." The institutionalization shall be a big boost to the integrity and image of the agency in dealing with the populace, especially during the conduct of lectures and information dissemination, wherein personnel of the Preventive Education and Community Involvement Service deliver lectures regarding the concept of a "Drug-Free Workplace" policy. Further, the Agency's participation in the promotion of the "National Dru-Free Program" will be strengthened. The Assessment Committee created as a result of this ReP shall spearhead and oversee the implementation of the drug-free policy in the Agency in line with the provisions of the RA 9165and the DDB Regulation Number 2, series of 2004. A monitoring and evaluation system will eventually be created to assess the effectiveness of the implementation and the adjustments on gray areas warranted by the results of evaluation. During the drafting of the implementing guidelines, committee members were selected through a stringent process based on their field of expertise and level of contribution in coming-up with guidelines that are holistic in scope. The set of guidelines, the first of its kind, will serve as the model and will hopefully be replicated in all workplaces, especially law enforcement units, via regulations by the Dangerous Drugs Board which has the authority to impose policy matters pertaining to drugs. At the end of ReP implementation period, the Assessment Committee will have been created and the Implementing Guidelines formulated, reviewed, and revised. It will then be well on the way to finalization and approval by the Director General.